Kephera Diagnostics, LLC
Publicly observedFramingham, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Framingham | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Kephera Diagnostics, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | LJFNSE6NM648 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant24 Aug 2026Publicly observed
NIH SBIR/STTR award: Rapid Diagnostic Immunoassay for Strongyloidiasis
USD 303,250.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: Peptide-based ELISA for laboratory diagnosis of sarcoidosis
USD 1,008,567.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: Peptide-based ELISA for laboratory diagnosis of sarcoidosis
USD 978,191.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2025Publicly observed
NIH SBIR/STTR award: Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
USD 123,606.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant1 May 2024Publicly observed
NIH SBIR/STTR award: Diagnostic assay for congenital Chagas disease
USD 303,250.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant10 Jan 2020Publicly observed
NIH SBIR/STTR award: Rapid Point-of-Care Assay for Diagnosis of Neurocysticercosis in Seizure Patients
USD 876,394.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant16 Jul 2019Publicly observed
NIH SBIR/STTR award: Biomarker-Based Test of Cure for Chagas Disease
USD 906,016.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant6 Mar 2019Publicly observed
NIH SBIR/STTR award: Hybrid ELISA: Simple and specific one-tier assay for Lyme disease
USD 714,666.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
- Grant7 Aug 2018Publicly observed
NIH SBIR/STTR award: Point-of-care diagnostic test for T. cruzi (Chagas) infection
USD 1,015,000.00 · National Institute of Allergy and Infectious Diseases · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.